LIFEWTR, the premium water brand that believes art is as essential to life as water, is committing to advancing arts education in schools nationwide as the foundation of where creativity begins. New research shows we are heading toward a creativity crisis in schools – 91% of American parents agree that arts education is important to teach children to think outside the box, yet 4 in 5 people say that arts education is not being offered as much as it once wasi. This week, in partnership with Americans for the Arts during its National Arts Action Summit, LIFEWTR announced its commitment to making every day vibrant by infusing creativity into schools across the U.S., reaching 10 million students through school and community beautification projects and arts education programming as part of its continued collaboration with Scholastic.
“At LIFEWTR we believe that arts education plays an invaluable role in helping students achieve success and reach their full potential in school and beyond,” said Alexis Porter, Senior Director, LIFEWTR Marketing. “Students involved in the arts are four times more likely to be recognized for academic achievementii, which is why it’s more important than ever to #BringArtBackToSchools. Through our collaboration with Scholastic and Americans for the Arts, we are making a concerted effort to impact 10 million students nationwide through arts education programming and to preserve the critical source of where creativity begins, in our schools.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8503551-pepsico-lifewtr-scholastic-macklemore-school-art-beautification-project/
The Celiac Disease Center at Columbia University, the premier center for celiac disease research and treatment, unveiled the I Didn’t Know video campaign, offering an inside look at the serious impact of celiac disease on patients at the 13th Anniversary gala on November 13th in New York City. The series chronicles the lives of several patients experiencing a wide range of debilitating symptoms associated with undiagnosed celiac disease, including an inability to walk, developmental delays, multiple miscarriages and infertility.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7322351-celiac-disease-center-at-columbia-university-public-service-announcements-and-gala/
Nintex, the recognized global leader in workflow and content automation (WCA), today released a new study revealing the top five most broken processes in American workplaces and how they contribute to employee satisfaction and performance.
The study, called the “Definitive Guide to America’s Most Broken Processes,” found that a third of employees at U.S. companies (with more than 1,000 employees) are currently looking for new jobs, with the vast majority (86 percent) citing their company’s broken processes as a driving factor behind this decision. One commonality found in the research is that the top five issues are unspecialized, repetitive tasks that fall in the long tail of business processes, which must be automated to drive efficiency, efficacy and employee satisfaction.
To view the multimedia release go to:
https://www.multivu.com/players/English/8146751-nintex-american-workplace-broken-processes-study/
Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation.
“My mother didn’t make it and unfortunately right now that’s a common story. But it doesn’t have to be the story permanently,” DeGraw said. “By funding research, the Lustgarten Foundation is going to change the course of this disease. I encourage everyone to get involved in some way – join a walk or make a donation.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213753-lustgarten-foundation-pancreatic-cancer-awareness/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Anyone who has seen the blockbuster movies The Thomas Crown Affair or Bullitt will want to read The Pursuit of Happiness, a new novel by the same writer, Alan Trustman. The highest paid screenwriter in Hollywood at one time, Trustman now turns his pen to fiction, which reads and moves with the same crime thriller speed as his movies.
From the opening chapter we are rocketed into the world of a Boston bad boy who is recruited to work for the government.
“All of the material in The Pursuit of Happiness is true,” says Trustman. “Not a lot of people know that Boston was the contract killing capitol of the country throughout the 1940s – 1970s. Maybe later. I did a lot of research on the Boston gang wars.”
Media Contact: For a review copy of Silver Dollar or to arrange an interview with Alan Trustman, contact Scott Lorenz of Westwind Communications Book Marketing at scottlorenz@westwindcos.com or by phone at 734-667-2090 http://www.book-marketing-expert.com Thriller
Online Registration Guidline
ACRI is specialized in providing Clinical Research Courses like Pg Diploma in clinical CDM and SAS course with guarantee internship in leading CRO’S & 100% Placement.
Reach us at:
Avigna Clinical Research Institute:-
No.33,3rd Floor,15th Cross,
2nd Phase,J.P.Nagar,100ft Ring Road,
Bangalore-560078
080-26588910 / 91-9741600499
http://www.acriindia.com
info@acriindia.com
GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first annual, “Innovation in Medical Cannabis Therapies” (IMCT) Symposium, held on Friday, November 9th at the “Keep Memory Alive” Event Center at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada. Throughout the day’s program, there was an emerging sense of heightened responsibility on the part of the cannabis industry to better address medical cannabis patients' needs through research and development of medical cannabis products that are better standardized, more easily-dosed, and made more widely-available to cannabis patients at a fair price.
To view the multimedia release go to:
https://www.multivu.com/players/English/8308958-gb-sciences-2018-medical-cannabis-therapies-symposium/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Cancer is the leading cause of death by disease in children from ages 1 to 19 in the U.S. Yet, childhood cancer research and services are vastly and consistently underfunded. This weekend, Northwestern Mutual financial professionals and employees will support the fight against childhood cancer through its nonprofit partner, Alex’s Lemonade Stand Foundation (ALSF), by holding nearly 200 lemonade stands as part of the Foundation’s national fundraising initiative, Alex’s Lemonade Days (June 12-14).
Founded by Alex Scott (1996-2004) in 2004, Alex’s Lemonade Days is a three-day national event that grew out of Alex’s front yard lemonade stand. During Alex’s Lemonade Days, dedicated volunteers host thousands of Alex’s Lemonade Stands across the country, raising more than $1 million for childhood cancer research. June 2015 will mark the 12th Annual Lemonade Days, and will continue Alex’s mission to raise money one cup of lemonade at a time, renewing her idea that any contributor, at any age, can make a difference.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7422153-northwestern-mutual-lemonade-days/
November is National Alzheimer’s Disease Awareness Month, a time to focus on finding ways to prevent the disease and enrich the lives of millions of Americans who live with, or care for, someone with Alzheimer’s. Brookdale, a leading owner and operator of senior living solutions throughout the United States, has a long-standing commitment to support research to reduce the impact of Alzheimer’s, which is the sixth leading cause of death in the United States.
To view Multimedia News Release, go to http://www.multivu.com/players/English/64011-brookdale-senior-living-alzheimer-awareness/
The First Graduation Ceremony of Nazarbayev University (NU) took place on June 15, 2015. The President of Kazakhstan, Nursultan Nazarbayev addressed the Class of 2015.
Nazarbayev University, created on the initiative of the President of Kazakhstan in 2010, is fast becoming a leading research university in Kazakhstan and the region. The first cohort of graduating students consists of 446 undergraduate and graduate students. Of the 365 bachelor degree holders, 115 have been accepted to Masters and PhD programs in leading universities of the world, some 90 graduates plan to continue their studies at Nazarbayev University; more than 80 received job offers from leading national and international companies, and another 50 are interviewing with prospective employers.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7560951-nazarbayev-university-graduation-ceremony/
